Brand
BE PHARMACEUTICALS AG
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for BE PHARMACEUTICALS AG and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-01-31FDA-DrugClass IIFosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
Lack of Sterility Assurance: Aseptic process simulation failure.
- 2023-09-20FDA-DrugClass IIPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Get notified about new BE PHARMACEUTICALS AG recalls
Free weekly digest. We email when a new federal recall affects BE PHARMACEUTICALS AG or anything else in your household.
Get the Sunday Brief